Supplementary Figure 1 from The Pretreatment Tumor Microenvironment Immune Status Determines Bacillus Calmette–Guerin Immunotherapy Response in Early-Stage Bladder Cancer

Authors:

Open Access

Supplementary Figure S1. MFAP2+ CAF density is an independent prognostic factor in BCG-treated patients.